Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

417

HTML

2544

Figures (1-7)

213

Tables (1-2)

199

Sum=3373

Feb 7, 2005 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Feb 7, 2005; 11(5): 634-640
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.634

Table 1 Antisense accessible regions of survivin mRNA shown by primer extension analysis.

Primer name	Product size of primerextension (bp)	3’ end site of primer extension (bp)	3’ end site of RNase Hcleavage (bp)	Antisense accessiblesites (bp)
P₁	42	255	254	235-254
	60	237	236	217-236
	70	227	226	207-226
	82	215	214	195-214
	90	207	206	187-206
	104	193	192	173-192
	118	179	178	159-178
	151	146	145	126-145
P₂	40	124	123	104-123
	70	94	93	74-93
	100	64	63	44-63
	118	46	45	26-45
	140	24	23	4-23

Citation: Tong QS, Zheng LD, Chen FM, Zeng FQ, Wang L, Dong JH, Lu GC. Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer. World J Gastroenterol 2005; 11(5): 634-640
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/634.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i5.634